Vitamin D, cardiovascular disease and mortality

A poor vitamin D status, i.e. low serum levels of 25-hydroxyvitamin D [25(OH)D], is common in the general population. This finding is of concern not only because of the classic vitamin D effects on musculoskeletal outcomes, but also because expression of the vitamin D receptor (VDR) and vitamin D me...

Full description

Saved in:
Bibliographic Details
Main Authors: Pilz, Stefan (Author) , Tomaschitz, Andreas (Author) , März, Winfried (Author) , Drechsler, Christiane (Author) , Ritz, Eberhard (Author) , Zittermann, Armin (Author) , Cavalier, Etienne (Author) , Pieber, Thomas R. (Author) , Lappe, Joan M. (Author) , Grant, William B. (Author) , Holick, Michael F. (Author) , Dekker, Jacqueline M. (Author)
Format: Article (Journal)
Language:English
Published: 17 June 2011
In: Clinical endocrinology
Year: 2011, Volume: 75, Issue: 5, Pages: 575-584
ISSN:1365-2265
DOI:10.1111/j.1365-2265.2011.04147.x
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1111/j.1365-2265.2011.04147.x
Get full text
Author Notes:Stefan Pilz, Andreas Tomaschitz, Winfried März, Christiane Drechsler, Eberhard Ritz, Armin Zittermann, Etienne Cavalier, Thomas R. Pieber, Joan M. Lappe, William B. Grant, Michael F. Holick and Jacqueline M. Dekker

MARC

LEADER 00000caa a2200000 c 4500
001 1827172266
003 DE-627
005 20231206084057.0
007 cr uuu---uuuuu
008 221215s2011 xx |||||o 00| ||eng c
024 7 |a 10.1111/j.1365-2265.2011.04147.x  |2 doi 
035 |a (DE-627)1827172266 
035 |a (DE-599)KXP1827172266 
035 |a (OCoLC)1389739079 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Pilz, Stefan  |e VerfasserIn  |0 (DE-588)121523756  |0 (DE-627)705511073  |0 (DE-576)292753683  |4 aut 
245 1 0 |a Vitamin D, cardiovascular disease and mortality  |c Stefan Pilz, Andreas Tomaschitz, Winfried März, Christiane Drechsler, Eberhard Ritz, Armin Zittermann, Etienne Cavalier, Thomas R. Pieber, Joan M. Lappe, William B. Grant, Michael F. Holick and Jacqueline M. Dekker 
264 1 |c 17 June 2011 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 15.12.2022 
520 |a A poor vitamin D status, i.e. low serum levels of 25-hydroxyvitamin D [25(OH)D], is common in the general population. This finding is of concern not only because of the classic vitamin D effects on musculoskeletal outcomes, but also because expression of the vitamin D receptor (VDR) and vitamin D metabolizing enzymes in the heart and blood vessels suggests a role of vitamin D in the cardiovascular system. VDR-knockout mice suffer from cardiovascular disease (CVD), and various experimental studies suggest cardiovascular protection by vitamin D, including antiatherosclerotic, anti-inflammatory and direct cardio-protective actions, beneficial effects on classic cardiovascular risk factors as well as suppression of parathyroid hormone (PTH) levels. In epidemiological studies, low levels of 25(OH)D are associated with increased risk of CVD and mortality. Data from randomized controlled trials (RCTs) are sparse and have partially, but not consistently, shown some beneficial effects of vitamin D supplementation on cardiovascular risk factors (e.g. arterial hypertension). We have insufficient data on vitamin D effects on cardiovascular events, but meta-analyses of RCTs indicate that vitamin D may modestly reduce all-cause mortality. Despite accumulating data suggesting that a sufficient vitamin D status may protect against CVD, we still must wait for results of large-scale RCTs before raising general recommendations for vitamin D in the prevention and treatment of CVD. In current clinical practice, the overall risks and costs of vitamin D supplementation should be weighed against the potential adverse consequences of untreated vitamin D deficiency. 
650 4 |a Animals 
650 4 |a Cardiovascular Diseases 
650 4 |a Humans 
650 4 |a Randomized Controlled Trials as Topic 
650 4 |a Receptors, Calcitriol 
650 4 |a Risk Factors 
650 4 |a Vitamin D 
650 4 |a Vitamin D Deficiency 
700 1 |a Tomaschitz, Andreas  |e VerfasserIn  |4 aut 
700 1 |a März, Winfried  |d 1958-  |e VerfasserIn  |0 (DE-588)1027603599  |0 (DE-627)729463605  |0 (DE-576)373454635  |4 aut 
700 1 |a Drechsler, Christiane  |e VerfasserIn  |4 aut 
700 1 |a Ritz, Eberhard  |d 1938-2023  |e VerfasserIn  |0 (DE-588)106673386  |0 (DE-627)610528866  |0 (DE-576)311552501  |4 aut 
700 1 |a Zittermann, Armin  |e VerfasserIn  |0 (DE-588)112570550  |0 (DE-627)691153035  |0 (DE-576)33559445X  |4 aut 
700 1 |a Cavalier, Etienne  |e VerfasserIn  |4 aut 
700 1 |a Pieber, Thomas R.  |e VerfasserIn  |4 aut 
700 1 |a Lappe, Joan M.  |e VerfasserIn  |4 aut 
700 1 |a Grant, William B.  |e VerfasserIn  |4 aut 
700 1 |a Holick, Michael F.  |e VerfasserIn  |4 aut 
700 1 |a Dekker, Jacqueline M.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Clinical endocrinology  |d Oxford [u.a.] : Wiley-Blackwell, 1972  |g 75(2011), 5, Seite 575-584  |h Online-Ressource  |w (DE-627)320438090  |w (DE-600)2004597-9  |w (DE-576)091142636  |x 1365-2265  |7 nnas  |a Vitamin D, cardiovascular disease and mortality 
773 1 8 |g volume:75  |g year:2011  |g number:5  |g pages:575-584  |g extent:10  |a Vitamin D, cardiovascular disease and mortality 
856 4 0 |u https://doi.org/10.1111/j.1365-2265.2011.04147.x  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20221215 
993 |a Article 
994 |a 2011 
998 |g 106673386  |a Ritz, Eberhard  |m 106673386:Ritz, Eberhard  |d 910000  |d 910100  |e 910000PR106673386  |e 910100PR106673386  |k 0/910000/  |k 1/910000/910100/  |p 5 
998 |g 1027603599  |a März, Winfried  |m 1027603599:März, Winfried  |d 60000  |d 61400  |e 60000PM1027603599  |e 61400PM1027603599  |k 0/60000/  |k 1/60000/61400/  |p 3 
999 |a KXP-PPN1827172266  |e 4231651752 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 15.12.2022"],"name":{"displayForm":["Stefan Pilz, Andreas Tomaschitz, Winfried März, Christiane Drechsler, Eberhard Ritz, Armin Zittermann, Etienne Cavalier, Thomas R. Pieber, Joan M. Lappe, William B. Grant, Michael F. Holick and Jacqueline M. Dekker"]},"recId":"1827172266","origin":[{"dateIssuedKey":"2011","dateIssuedDisp":"17 June 2011"}],"language":["eng"],"person":[{"display":"Pilz, Stefan","role":"aut","family":"Pilz","given":"Stefan"},{"role":"aut","display":"Tomaschitz, Andreas","given":"Andreas","family":"Tomaschitz"},{"family":"März","given":"Winfried","display":"März, Winfried","role":"aut"},{"given":"Christiane","family":"Drechsler","role":"aut","display":"Drechsler, Christiane"},{"family":"Ritz","given":"Eberhard","display":"Ritz, Eberhard","role":"aut"},{"family":"Zittermann","given":"Armin","display":"Zittermann, Armin","role":"aut"},{"given":"Etienne","family":"Cavalier","role":"aut","display":"Cavalier, Etienne"},{"family":"Pieber","given":"Thomas R.","display":"Pieber, Thomas R.","role":"aut"},{"family":"Lappe","given":"Joan M.","display":"Lappe, Joan M.","role":"aut"},{"family":"Grant","given":"William B.","display":"Grant, William B.","role":"aut"},{"role":"aut","display":"Holick, Michael F.","given":"Michael F.","family":"Holick"},{"role":"aut","display":"Dekker, Jacqueline M.","given":"Jacqueline M.","family":"Dekker"}],"relHost":[{"type":{"bibl":"periodical","media":"Online-Ressource"},"id":{"eki":["320438090"],"doi":["10.1111/(ISSN)1365-2265"],"zdb":["2004597-9"],"issn":["1365-2265"]},"part":{"issue":"5","pages":"575-584","text":"75(2011), 5, Seite 575-584","volume":"75","extent":"10","year":"2011"},"pubHistory":["1.1972 -"],"recId":"320438090","origin":[{"publisherPlace":"Oxford [u.a.] ; Oxford [u.a.] ; Oxford [u.a.]","dateIssuedKey":"1972","dateIssuedDisp":"1972-","publisher":"Wiley-Blackwell ; Blackwell Science ; Blackwell"}],"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Clinical endocrinology","title":"Clinical endocrinology"}],"note":["Gesehen am 07.05.08"],"disp":"Vitamin D, cardiovascular disease and mortalityClinical endocrinology"}],"title":[{"title_sort":"Vitamin D, cardiovascular disease and mortality","title":"Vitamin D, cardiovascular disease and mortality"}],"id":{"eki":["1827172266"],"doi":["10.1111/j.1365-2265.2011.04147.x"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"physDesc":[{"extent":"10 S."}]} 
SRT |a PILZSTEFANVITAMINDCA1720